Does Medicare cover hiatal hernia surgery?

Yes, the surgery itself is covered — classical laparoscopic or open Nissen/Toupet fundoplication is Medicare's accepted surgical standard for hiatal hernia repair, not something insurers make you clear a special hurdle for. The more surprising finding is what happens if you're weighing a newer, less invasive alternative instead: both Medicare's own coverage policy and two commercial insurers we checked treat those newer procedures very differently. Here's the full picture, plus the honest answer on recovery equipment: none of it has a Medicare billing code.

The fact

CMS's own coverage policy for anti-reflux procedures (LCD L35080) governs only the newer endoscopic alternatives — transesophageal radiofrequency (Stretta), transoral incisionless fundoplication (TIF), and endoscopic bulking-agent injection — and lists all of them as non-covered/investigational.

Classical laparoscopic or open Nissen/Toupet fundoplication appears in this same LCD's own bibliography only as the COMPARATOR those newer techniques are measured against — it isn't itself the subject of this or any other LCD found in this research pass, meaning it's covered under Medicare's general medical-necessity standard, not a special policy.

Source: CMS Local Coverage Determination L35080, 'Select Minimally Invasive GERD Procedures'

The surprising finding: newer procedures face a stricter published bar

Two commercial insurer medical policies, cross-checked independently, show the same structural pattern: a specific, numeric, published bar for the newer procedures — and no equivalent public threshold for classical fundoplication.

“Magnetic esophageal sphincter augmentation to treat gastroesophageal reflux disease is considered MEDICALLY NECESSARY when the following criteria are met: Patient has a history of severe GERD for ≥1 year with daily symptoms, AND Patient has tried and failed optimal non-surgical management of symptoms, including lifestyle modification, weight loss (if indicated), and daily proton pump inhibitor use for ≥ 6 months… Transoral incisionless fundoplication (TIF)… is considered MEDICALLY NECESSARY… [when] the same ≥1 year severe GERD / ≥6 month failed PPI trial criteria are met.”

— Blue Cross Blue Shield of Massachusetts, Medical Policy #920, “Surgical and Transesophageal Endoscopic Procedures to Treat Gastroesophageal Reflux Disease” (source)

That same BCBSMA policy frames classical fundoplication as the established option newer procedures are compared against, not the one facing the numeric bar: “Surgical treatments are available for these individuals, primarily a Nissen fundoplication performed either laparoscopically or by open surgery. A number of less invasive procedures are also being evaluated as an intermediate option between medical therapy and surgery.”

“An adequate trial of medical therapy would be at least 4 concurrent months of Proton Pump Inhibitor (PPI) use. [This criterion is stated for Transoral Incisionless Fundoplication (TIF).] Fundoplication Surgery [i.e., classical laparoscopic hiatal hernia repair] Requires Level of Care Review AND Kaiser Permanente has elected to use the Fundoplication and Hiatal Hernia Repair, by Laparoscopy (KP-S-505) MCG Care Guideline for medical necessity determinations.”

— Kaiser Permanente Washington, Clinical Review Criteria, “Fundoplication Surgery & Treatment of Gastroesophageal Reflux Disease” (source)

Same pattern as BCBSMA: Kaiser publishes a specific numeric PPI-trial threshold (4 months) for TIF — but for classical fundoplication itself, the policy states it defers to a proprietary, non-public MCG clinical guideline rather than disclosing a numeric threshold in this public document. This is a pattern observed across two payers, cross-checked and consistent with each other on the structural point — not a universal rule every insurer follows identically. If you're weighing the newer LINX device or an incisionless procedure against traditional fundoplication, expect the newer option to require more documented proof up front.

What about recovery equipment — is any of it Medicare DME?

No. Checked directly against this site's own 68-code Medicare dataset: zero hits for “hiatal,” “fundoplication,” “nissen,” “toupet,” or “wedge.” That's expected, not a gap — that dataset was built to track the mobility/bathroom-DME code set (walkers, canes, crutches, commodes, bath-safety equipment, hospital beds, patient lifts, seat-lift mechanisms, manual wheelchairs), and hiatal hernia repair via laparoscopic ports isn't a mobility-limiting surgery the way a joint replacement is.

Hiatal-hernia-checklist items with no HCPCS code in Medicare's DME fee schedule
ItemWhat we found
Torso sleep wedge No HCPCS code — same finding as this site's knee, hip, shoulder, and hernia hubs for leg- and torso-elevation wedges alike.
Personal blender A small kitchen appliance, never DME-coded, same finding as this site's wisdom-teeth hub research for the identical category.
Heating pad No HCPCS code — not billed as DME, same finding as this site's c-section and hernia hubs.
Pill crusher / splitter No HCPCS code found in any coding reference checked — a pharmacy/kitchen accessory, not a classified medical device.

What about FSA or HSA?

We didn't research FSA/HSA eligibility to primary-source depth for this hub. Hiatal hernia repair with fundoplication is unambiguously a medically necessary surgical procedure — it doesn't carry the same “surprising exclusion” weight an elective procedure can. Confirm eligibility for any specific recovery-equipment purchase with your own FSA or HSA plan administrator before assuming reimbursement.

This page explains what CMS's published coverage policy and two commercial insurers' published medical policies say — it isn't a coverage determination for your specific claim. A Medicare Advantage plan or your own commercial plan can set different rules than the figures discussed here; confirm your own situation with your plan or surgeon's office before you schedule.

Go deeper

Sources

  1. CMS Local Coverage Determination L35080, "Select Minimally Invasive GERD Procedures" — the basis for this page's core finding — governs only the newer endoscopic alternatives; fetched live 2026-08-05
  2. Blue Cross Blue Shield of Massachusetts, Medical Policy #920, "Surgical and Transesophageal Endoscopic Procedures to Treat Gastroesophageal Reflux Disease" — the >=1-year-symptoms / >=6-month-PPI-trial numeric gate for LINX/TIF; fetched live 2026-08-05
  3. Kaiser Permanente Washington, Clinical Review Criteria, "Fundoplication Surgery & Treatment of Gastroesophageal Reflux Disease" — the 4-month PPI-trial threshold for TIF and the proprietary-MCG-guideline finding for classical fundoplication; fetched live 2026-08-05
  4. data/coverage_status.json (68 HCPCS codes) + data/dmecs_products.json — direct keyword scan for hiatal/fundoplication/nissen/toupet/wedge — zero matches
  5. VerifiedCareData dataset.json (CC-BY-4.0) — every coverage fact above in one machine-readable endpoint